SUBSCRIBE Subscribe to our RSS Feed

CMLHope.Com

A Worldwide Support Network For Chronic Myelogenous Leukemia

  • home
  • About
  • Contact
  • Sponsored By RealEstateZoo.Com

Archives

  • May 2012
  • March 2012
  • February 2012
  • January 2012
  • October 2011
  • September 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • February 2006
  • January 2006
  • December 2005
  • November 2005
  • October 2005
  • September 2005
  • August 2005
  • July 2005
  • June 2005
  • May 2005
  • April 2005
  • March 2005
  • February 2005
  • January 2005
  • December 2004
  • November 2004
  • October 2004
  • September 2004
  • August 2004
  • July 2004
  • June 2004

Recent Posts

  • E2F1?dependent pathways are involved in amonafide analogue 7?d?induced DNA damage, G2/M arrest and apoptosis in p53?deficient K562 cells
  • Medical conditions and risk of adult myeloid leukemia
  • Hematopoietic Interferon Regulatory Factor 8-Deficiency Accelerates Atherosclerosis in Mice.
  • BCR-JAK2 fusion as a result of a translocation (9;22)(p24;q11.2) in a patient with CML-like myeloproliferative disease
  • A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report
  • Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era
  • Gastric Antral Vascular Ectasia in a Patient with GIST after Treatment with Imatinib: Case Report and Literature Review
  • Spinophilin: a new tumor suppressor at 17q21.
  • Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors
  • Genetic testing behavior and reporting patterns in electronic medical records for physicians trained in a primary care specialty or subspecialty.
  • Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia
  • Long?term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study
  • Somatic mutations in the HLA genes of patients with hematological malignancy
  • Leukapheresis in management hyperleucocytosis induced complications in two pediatric patients with chronic myelogenous leukemia
  • 2??Chloro?4??aminoflavone Derivatives Selectively Targeting Hepatocarcinoma Cells: Convenient Synthetic Process, G2/M Cell Cycle Arrest and Apoptosis Triggers

 

February 2007
M T W T F S S
« Jan   Mar »
 1234
567891011
12131415161718
19202122232425
262728293031  

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

Medical Articles 2/17

Posted by rob on February 17, 2007 under Uncategorized | Be the First to Comment

Polycythemia associated with the JAK2V617F mutation emerged during treatment of chronic myelogenous leukemia.

Information is temporarily unavailable.
[Innovation
of Clinical Trials for Anti-Cancer Drugs in Japan-Proposals from
Academia with Special Reference to the Development of Novel Bcr-Abl/Lyn
Tyrosine Kinase Inhibitor INNO-406 (NS-187) for Imatinib-Resistant
Chronic Myelogenous Leukemia.]
Information is temporarily unavailable.
P-glycoprotein quantitation in acute leukemia.
Information is temporarily unavailable.
Initial presentation as sclerotic bone metastases in a patient with acute myelogenous leukemia.
Information is temporarily unavailable.
Predicting chronic leukaemias from assessment of complete peripheral blood counts.

Add A Comment

You must be logged in to post a comment.

home top

Site Information

© 2012 CMLHope.Com
Ministry Free Theme
by eGrace Creative.

Pages

  • Home
  • About
  • Contact
  • Sponsored By RealEstateZoo.Com

Blogroll

    Contributors

    • MedWorm Query: +chronic +myelogenous +leukemia
    • pubmed: myelogenous